Land: Canada
Taal: Engels
Bron: Health Canada
MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE)
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
J01AA08
MINOCYCLINE
50MG
CAPSULE
MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) 50MG
ORAL
100
Prescription
TETRACYCLINES
Active ingredient group (AIG) number: 0131309001; AHFS:
CANCELLED POST MARKET
2014-09-19
PRESCRIBING INFORMATION RATIO-MINOCYCLINE (MINOCYCLINE HYDROCHLORIDE) 50 MG AND 100 MG CAPSULES ANTIBIOTIC ratiopharm inc. DATE OF PREPARATION: Canada, J7J 1P3 2002.04.29 DATE OF REVISION: 2010.12.17 Control #: 143043 Page 2 COMPLETE PRESCRIBING INFORMATION ratio-MINOCYCLINE (minocycline hydrochloride) THERAPEUTIC CLASSIFICATION Antibiotic ACTION RATIO-MINOCYCLINE (minocycline hydrochloride) is a tetracycline with antibacterial activity against some Gram-negative and Gram-positive organisms. The action of RATIO- MINOCYCLINE is primarily bacteriostatic and it is thought to exert its antimicrobial effect by the inhibition of protein synthesis. INDICATIONS AND CLINICAL USE RATIO-MINOCYCLINE (minocycline hydrochloride) may be indicated for the treatment of the following infections due to susceptible strains of the designated organisms: Gall bladder infections caused by _Escherichia coli_. Urinary tract infections: cystitis, gonorrhea, pyelonephritis caused by _ Escherichia coli_, _Proteus_ species, _Klebsiella_ species, _Enterobacter aerogenes_, _Neisseria gonorrhea_. When penicillin is contraindicated, RATIO-MINOCYCLINE may be employed as an alternative drug in the treatment of anal and pharyngeal gonorrhea and syphilis. Page 3 Skin and soft tissue infections: abscess, cellulitis, furunculosis, impetigo and pyoderma caused by: _Staphylococcus _ _epidermidis_, _Staphylococcus _ _aureus_, _Streptococcus _ _pyogenes_, _Proteus_ species, _Escherichia coli_. Although tetracyclines are not the drugs of choice in any staphylococcal or streptococcal infection, RATIO-MINOCYCLINE could be useful in circumstances where these organisms are shown to be resistant to other agents but sensitive to RATIO-MINOCYCLINE. Bacterial evaluation of clinical cases involving _Proteus_ suggests a relatively lower success rate may be expected where these organisms are concerned. Respiratory tract infections: bronchitis, pharyngitis, pneumonia, bronchopneumonia, sinusitis and tonsillitis caused by: _Haemophilus _ _influenzae_, _Klebsiella_ speci Lees het volledige document